Frank BurrellScientific Storytelling
Matthew DurhamOmnidynamic Marketing
Stacey GandlerBrand Nourishment
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
Liz KaneImpactful Strategy
Brenda SnowAuthentic Patient Voice
Joey CohenMedication Adherence
Bud BilanichSuccess Coach
Amy GilesIncreasing Engagement
Pat PurcellMeeting Engagement
Paul TheisenPatient Acquisition
Matt TurnerPatient Affordability
David LinetskyPoint-of-Care Marketing
Phase 2 cancer study will evaluate T cell-activating immunotherapy MEDI0457 with MedImmune’s durvalumab targeting several ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email